These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 564482)

  • 41. Anti-AChR antibodies, thymic histology, and T cell subsets in myasthenia gravis.
    Berrih S; Morel E; Gaud C; Raimond F; Le Brigand H; Bach JF
    Neurology; 1984 Jan; 34(1):66-71. PubMed ID: 6228745
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Leukoplasmapheresis for myasthenia gravis. Acetylcholine receptor antibody production.
    Seybold ME; Tsoukas C; Lindstrom J; Fong S; Vaughan J
    Arch Neurol; 1982 Jul; 39(7):433-5. PubMed ID: 6980639
    [No Abstract]   [Full Text] [Related]  

  • 43. [Myasthenia gravis in newborn infants--pathological mechanism, clinical symptomatology and therapeutic procedures].
    Krauze M; Musialik E; Swietliński J; Litwa K; Latko E; Górny J; Sobczyk J
    Wiad Lek; 1992 Aug; 45(15-16):610-4. PubMed ID: 1488831
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intravenous immune globulin in myasthenia gravis.
    Gajdos P
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):49-51. PubMed ID: 8033435
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
    Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
    Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis.
    Guptill JT; Juel VC; Massey JM; Anderson AC; Chopra M; Yi JS; Esfandiari E; Buchanan T; Smith B; Atherfold P; Jones E; Howard JF
    Autoimmunity; 2016 Nov; 49(7):472-479. PubMed ID: 27684107
    [TBL] [Abstract][Full Text] [Related]  

  • 47. New antigen for antibody detection in myasthenia gravis.
    Gotti C; Mantegazza R; Clementi F
    Neurology; 1984 Mar; 34(3):374-7. PubMed ID: 6538281
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.
    Peeler CE; De Lott LB; Nagia L; Lemos J; Eggenberger ER; Cornblath WT
    JAMA Neurol; 2015 Oct; 72(10):1170-4. PubMed ID: 26258604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An enzyme-linked immunosorbent assay for antibodies against saline-soluble muscle components in myasthenia gravis.
    Akazawa S; Furukawa S; Kamo I; Furukawa Y; Satoyoshi E; Hayashi K
    J Immunol Methods; 1986 Nov; 94(1-2):161-7. PubMed ID: 3782808
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 2. Clinical and serological follow-up of individual patients.
    Oosterhuis HJ; Limburg PC; Hummel-Tappel E; The TH
    J Neurol Sci; 1983 Mar; 58(3):371-85. PubMed ID: 6842265
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Pathogenic antibodies in myasthenia gravis].
    Motomura M
    Brain Nerve; 2010 Apr; 62(4):411-8. PubMed ID: 20420182
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Remission of myasthenia gravis following plasma-exchange.
    Pinching AJ; Peters DK
    Lancet; 1976 Dec; 2(8000):1373-6. PubMed ID: 63848
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of neonatal myasthenia gravis with antibodies against the fetal acetylcholine receptor.
    Vernet-der Garabedian B; Lacokova M; Eymard B; Morel E; Faltin M; Zajac J; Sadovsky O; Dommergues M; Tripon P; Bach JF
    J Clin Invest; 1994 Aug; 94(2):555-9. PubMed ID: 8040310
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clonotypic analysis of the antibody response to the acetylcholine receptor in experimental autoimmune myasthenia gravis.
    Brown RM; Krolick KA
    J Neuroimmunol; 1988 Sep; 19(3):205-22. PubMed ID: 3261738
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term effects of repeated plasma exchange in myasthenia gravis.
    Newsom-Davis J; Wilson SG; Vincent A; Ward CD
    Lancet; 1979 Mar; 1(8114):464-8. PubMed ID: 85055
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HLA antigens and acetylcholine receptor antibody in the subclassification of myasthenia gravis in Hong Kong Chinese.
    Hawkins BR; Ip MS; Lam KS; Ma JT; Wy CL; Yeung RT; Dawkins RL
    J Neurol Neurosurg Psychiatry; 1986 Mar; 49(3):316-9. PubMed ID: 3958744
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Correlation between acetylcholine receptor antibody levels and thymic pathology in myasthenia gravis: a review.
    Huang GZ; Lo YL
    J Clin Neuromuscul Dis; 2013 Jun; 14(4):209-17. PubMed ID: 23703018
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis.
    Higuchi O; Hamuro J; Motomura M; Yamanashi Y
    Ann Neurol; 2011 Feb; 69(2):418-22. PubMed ID: 21387385
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
    Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
    Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti AChR antibody: relevance to diagnosis and clinical aspects of myasthenia gravis.
    Mantegazza R; Pareyson D; Baggi F; Romagnoli P; Peluchetti D; Sghirlanzoni A; Cornelio F
    Ital J Neurol Sci; 1988 Apr; 9(2):141-5. PubMed ID: 3397267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.